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O R I G I N A L  A R T I C L E
ultifocal intraocular lenses (IOLs) enable spec-
tacle independence1 by providing several points 
of focus. A new generation of multifocal IOLs, 
known as trifocal IOLs (designed with three focal points) en-
tered the European market in 2010, with the launch of the 
FineVision/MicroF IOL (PhysIOL, Liège, Belgium). Many 
studies describing optical bench testing and clinical out-
comes for this IOL have been published since then.
The presence of astigmatism in multifocal IOLs scat-
ters each point of focus, resulting in multifocality failure. 
Therefore, astigmatism correction should also be a surgical 
goal. An accurate alignment of the toric IOL with the astigma-
tism axis is key for maximum vision correction. This can only 
be achieved if the IOL remains stable within the eye (ie, it 
must not rotate after implantation). The original FineVision/
MicroF IOL, a trifocal IOL model designed for microincision 
cataract surgery, was adapted with a new double C-loop hap-
tic design that should guarantee the IOL’s rotational stability. 
This new IOL model, which includes a toric component, was 
named POD FineVision.
In this study, we assessed the effect on rotational and 
capsular centration stability of this new haptic design and 
whether or not this leads to an improved visual performance 
to validate the material and the design of the POD FineVision 
IOL for toric versions.
PATIENTS AND METHODS
Study deSign
In this randomized controlled trial, we compared the effi-
cacy and rotational stability of two IOLs: a hydrophilic acryl-
MABSTRACT
PURPOSE: To compare visual outcomes, rotational 
stability, and centration in a randomized controlled trial 
in patients undergoing cataract surgery who were bilat-
erally implanted with two different trifocal intraocular 
lenses (IOLs) with a similar optical zone but different 
haptic shape.
METHODS: Twenty-one patients (42 eyes) with cataract 
and less than 1.50 D of corneal astigmatism under-
went implantation of one FineVision/MicoF IOL in one 
eye and one POD FineVision IOL in the contralateral eye 
(PhysIOL, Liège, Belgium) at IOA Madrid Innova Ocular, 
Madrid, Spain. IOL allocation was random. Outcome 
measures, all evaluated 3 months postoperatively, in-
cluded monocular and binocular uncorrected distance 
(UDVA), corrected distance (CDVA), distance-corrected 
intermediate (DCIVA), and near (DCNVA) visual acuity 
(at 80, 40, and 25 cm) under photopic conditions, re-
fraction, IOL centration, haptic rotation, dysphotopsia, 
objective quality of vision and aberration quantification, 
patient satisfaction, and spectacle independence.
RESULTS: Three months postoperatively, mean mon-
ocular UDVA, CDVA, DCIVA, and DCNVA (40 cm) under 
photopic conditions were 0.04 ± 0.07, 0.01 ± 0.04, 
0.15 ± 0.11, and 0.16 ± 0.08 logMAR for the eyes im-
planted with the POD FineVision IOL and 0.03 ± 0.05, 
0.01 ± 0.02, 0.17 ± 0.12, and 0.14 ± 0.08 logMAR 
for those receiving the FineVision/MicroF IOL. Moreover, 
the POD FineVision IOL showed similar centration (P 
> .05) and better rotational stability (P < .05) than 
the FineVision/MicroF IOL. Regarding halos, there was 
a minimal but statistically significant difference, obtain-
ing better results with FineVision/MicroF. Full spectacle 
independence was reported by all patients.
CONCLUSIONS: This study revealed similar visual out-
comes for both trifocal IOLs under test (POD FineVision 
and FineVision/MicroF). However, the POD FineVision 
IOL showed better rotational stability, as afforded by its 
design.
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ic (26%) trifocal IOL (POD FineVision) and another 
hydrophilic acrylic (25%) trifocal IOL (FineVision/
MicroF). Both of them have exactly the same design 
for the optical zone.
The study adhered to the tenets of the Declaration 
of Helsinki and was approved by the local ethical com-
mittee. The risk of binocular imbalance resulting from 
the implantation of two different IOL models was care-
fully considered. It was estimated to be minimal be-
cause the two IOL models provide the same MTF and 
transmittance curves when tested on an optical bench. 
All patients received sufficient information about the 
study before providing written informed consent.
The epiR package 0.9 to 30AQ1 was used to deter-
mine the cohort size with an average 0.03 logMAR, a 
discrimination of one logMAR line in visual acuity, 
with a standard deviation of 0.08. Based on these as-
sumptions, with an alpha level of 0.05 and power of 
0.9, it was calculated that 9 patients were required in 
each group.
Selection criteria were the need for bilateral cata-
ract surgery, no ocular comorbidities, and realistic 
expectations by the patient. Twenty-one patients re-
ceived both IOLs. Following random allocation, the 
POD FineVision IOL was implanted in one eye and the 
FineVision/MicroF IOL in the fellow eye. The selected 
patients had binocular age-related cataract with preoper-
ative corneal astigmatism less than 1.50 D, a preoperative 
logMAR visual acuity greater than 1.0, and normal find-
ings in their medical record and physical examination 
unless the investigator considered a particular abnormal-
ity to be clinically irrelevant.
Any of the following precluded an individual from 
participating in the study: ophthalmic diseases such 
as pseudoexfoliation syndrome, floppy iris syndrome, 
corneal pathologies, retinal pathology (diabetic macu-
lopathy, myopic maculopathy, or age-related macular 
degeneration) and history of ocular surgery or trauma.
iOL deScriptiOn
Both IOLs evaluated in this study are aspheric trifo-
cal diffractive IOLs manufactured by PhysIOL (Liège, 
Belgium). They have exactly the same diffractive pat-
tern and a similar refractive index (1.46 and 1.47), 
which means equivalent curvatures. The POD FineVi-
sion (Figure A, available in the online version of this 
article) is a double C-loop IOL with 5° angulation made 
of 26% hydrophilic material with ultraviolet filtration 
and a blue-light blocker. The optic body diameter is 6 
mm and the overall diameter is 11.4 mm. It is available 
in powers ranging from +6.00 to +35.00 D. The FineVi-
sion/MicroF (Figure B, available in the online version 
of this article) is a four-loop IOL with 5° angulation 
made of 25% hydrophilic material with ultraviolet fil-
tration and a blue-light blocker. The optic body diame-
ter is 6.15 mm and the overall diameter is 10.75 mm. It 
is available in powers ranging from +10.00 to +35.00 D.
Marking MethOd
The marking method used in this study was de-
scribed previously by Garzón et al.2 During the preop-
erative preparation of the patient, two marks were made 
at the limbus, on the horizontal axis (0° to 180°), using 
a fine-tipped gentian violet marker (Devon Skin Mark-
er, Fine Tip 151): one at the 9-o’clock position and the 
other at the 3-o’clock position under slit-lamp observa-
tion. A photograph was then taken of the patient stand-
ing at least 2.5 m away from the camera, with the head 
in its normal position (no chinrest or other support was 
used). Both eyes were kept open at all times, thus avoid-
ing the cyclotorsion that can occur during blinking. Fur-
thermore, images were always taken at a distance to pre-
vent cyclotorsion, which might occur when looking at 
a close object. The position of the surgeon-made marks 
was measured on the acquired image. Thus, once a pa-
tient was supine, the exact position of the marks was 
well established, irrespective of any cyclotorsion that 
might occur during surgery. The camera used to take 
the above-mentioned preoperative images was a Nikon 
Coolpix P90 cameraAQ1, with a 26- to 624-mm lens (35-
mm equivalent), a charge coupled device of 12.10 effec-
tive megapixels, and a 24× (optical)/4× (digital) zoom. 
The camera was placed on a tripod and connected to 
a bubble level to ensure the photograph was perfectly 
straight. The optical zooming option allowed us to si-
multaneously photograph both eyes. The photograph 
was then exported to a computer equipped with the 
Scale 2.0 package (Software R. Sgrillo, BrazilAQ2) to 
enable precise angle measurements. On the photograph, 
we measured the angle the corneal marks formed with 
the horizontal line that transects the corneal reflex (Fig-
ure 1). This provided the exact position of the marks 
and their angular position relative to the ‘real’ 0° to 180° 
line. Next, once the patient was lying down, the surgeon 
marked the axis that was to be aligned with the IOL’s in-
dex marks. For this purpose we used Méndez’s ring and 
took the initial marks as reference, with correction for 
their angular position relative to the real 0° to 180° line. 
Finally, the preoperative image and the last photograph 
obtained during surgery showing the final IOL’s axis po-
sition were compared to calculate the misalignment due 
to the marking method.
SurgicaL prOcedure
The same surgeon (FP) performed all surgeries. All 
surgery was done under topical anesthesia. For phaco-
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emulsification, the surgeon made a 2.2-mm clear-cor-
nea incision. Next, a continuous curvilinear capsu-
lorhexis measuring approximately 5.5 mm in diameter 
was created. Two ophthalmic viscosurgical devices 
were used during the surgery: the cohesive Healon 
(Abbott Laboratories Inc., Abbot Park, IL) and the dis-
persive Amvisc (Bausch & Lomb, Inc., Rochester, NY). 
The IOL was then implanted in the capsular bag with 
a single-use injection system (Microset; PhysIOL). Fol-
lowing IOL implantation, all traces of ophthalmic vis-
cosurgical devices were removed.
exaMinatiOn
Preoperative evaluations included anterior cham-
ber depth, axial length, corneal power, white-to-white 
distance, corrected distance visual acuity, intraocular 
pressure, and photopic and mesopic pupil diameters.
Patients were seen at 1 day, 1 week, 1 month, and 3 
months following surgery. At each visit, visual acuity 
was measured and patients underwent a slit-lamp ex-
amination. At the 1-week and 1-month postoperative 
visits, refraction was also assessed.
Additional variables that were measured in the 
3-month postoperative visit included: Objective Scat-
tering Index (OSI), MTF, and Strehl ratio, which were 
measured with the OQAS (Visiometrics SL, Terrassa, 
Spain); centration (mm), determined from slit-lamp 
photographs; rotation (°), determined from slit-lamp 
photographs; ocular aberrations (spherical aberration 
and tilt), using the OPD Scan III-refractive power/cor-
neal analyzer system (Nidek Co., Ltd.AQ1); halos, using 
the Halo v1.0 software (Laboratory of Vision Sciences 
and Applications, University of Granada, Granada, 
Spain); refraction, visual acuity (logMAR) at any dis-
tance (4 m and 80, 40, and 25 cm) with Early Treatment 
Diabetic Retinopathy Study and Spanish RADNER Vis-
sum chart; subjective satisfaction level, assessed by 
means of an ad hoc questionnaire written for this par-
ticular purpose; and pupil size in photopic and mesopic 
conditions, measured with the OPD Scan III.
StabiLity aSSeSSMent
Centration and rotation were evaluated using vali-
dated methods.3,4 IOL rotation was assessed by retro-
spective analysis of slit-lamp photographs via a trian-
gulation method (IOL mark, IOL center, and anatomic 
mark), using the sharpest optic–haptic junction as a 
mark of the IOL positioning with respect to time.
The position of the IOL’s geometric center relative 
to the geometric center of the dilated pupil was deter-
mined by the same observer using a program written 
in MathLab 6.5 (The MathWorks, Inc., Natick, MA) to 
process digital photographs of the pupil. A first ellipse 
was drawn following the contours of the IOL optical 
zone, and a second one was drawn following the bor-
der of the limbus. The computer then calculated the 
shift between these two ellipses’ geometric centers.
As part of the regular postoperative follow-up, digi-
tal retroilluminated slit-lamp photographs of each eye 
were taken the day of the surgery, and at 1 day, 1 week, 
1 month, and 3 months postoperatively. Before slit-
lamp photographs were taken, eyes were dilated to a 
pupil diameter of at least 6.5 mm by means of a drop of 
tropicamide 0.5% solution (MonofreeAQ1).
Photographs were analyzed using custom-made pro-
cessing routines written in MathLab (The MathWorks, 
Inc.). This software program uses an easily recogniz-
able landmark on the sclera (eg, a blood vessel), a land-
mark on the IOL (eg, the haptic), and the IOL’s optic 
center to define a triangle (Figure 2). These landmarks 
were defined by means of mouse clicks on the pho-
tographs, and the IOL’s optic center was determined 
by fitting an ellipse onto the IOL optic edge. Next, the 
IOL’s orientation angle θ was defined by tracing the 
Figure 1. (A) Two marks placed at the limbus on the horizontal axis (0° to 180º) at the 9- and 3-o’clock positions performed under slit-lamp observa-
tion. (B-C) The exact position of the marks and their angular difference with respect to the “real” 0° to 180° line.
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lines connecting the scleral landmark and the IOL 
landmark with the IOL optic center. Because the shape 
and center of the limbus do not change significantly 
over a 6-month period, it is possible to determine 
changes in IOL orientation over time by comparing the 
corresponding triangles from photographs taken at dif-
ferent follow-up visits.
The photographic evaluation method used for im-
age acquisition required that at least three-quarters of 
the IOL optic edge outline and recognizable landmarks 
on the IOL and the sclera were visible in the photo-
graph for accurate determination of the change in IOL 
orientation. Photographs that did not meet these crite-
ria were not evaluated.
For the purpose of this study, a positive rotation an-
gle θ was defined as the angle resulting from a clockwise 
rotation and a negative rotation angle θ was defined as 
the angle resulting from a counterclockwise rotation.
StatiSticaL anaLySiS
For all quantitative variables, summary tables con-
taining mean, standard deviation, and maximum and 
minimum values were created. The R code was used 
to determine differences between groups and between 
preoperative and postoperative assessments. Due to 
the sample size, the robust non-parametric Wilcoxon 
rank sum test was employed. In all tests, a P value of 
.05 was considered significant. An odds ratio analy-
sis was performed to compare the number of rotations 
greater than 5° between the two groups.
RESULTS
baSeLine characteriSticS
The FineVision/Micro F and the POD FineVision 
groups were comparable across all preoperative pa-
rameters (Table A, available in the online version of 
this article). This was expected because the groups 
were matched: for each patient one eye received the 
FineVision/MicroF lens and the fellow eye received 
the POD FineVision lens.
The preoperative visual acuity was 0.16 ± 0.16 log-
MAR (range: 0.8 to 0.05 logMAR) for the FineVision/
MicroF group and 0.17 ± 0.18 logMAR (range: 0.7 
to 0.05 logMAR) for the POD FineVision group. The 
mean age at the time of surgery was 64 ± 9.0 years.AQ3
SurgicaL and cLinicaL OutcOMeS
All surgeries were uneventful. One eye implanted 
with the POD FineVision IOL had a Seidel leakage 
that required a suture. Posterior capsule opacification 
could be seen 3 months postoperatively in one eye 
that had been implanted with the POD FineVision 
IOL. One patient implanted with the POD FineVision 
IOL in his first eye experienced pronounced negative 
dysphotopsia. However, it resolved after 3 months 
and the patient accepted surgery in the fellow eye. 
No postoperative dysphotopsia was reported for this 
fellow eye.
ViSuaL acuity
As can be seen in Table 1, all postoperative visual 
acuity values were better than 0.3 logMAR. No sig-
nificant difference could be observed between the two 
groups at any follow-up visit.
refractiOn
At 3 months postoperatively, the spherical equiva-
lent was 0.03 ± 0.31 D (range: -0.5 to 0.5 D), the cylinder 
was -0.03 ± 0.11 D (range: -0.5 to 0 D), and the sphere 
was 0.04 ± 0.29 D (range: -0.5 to 0.5 D) for the POD 
FineVision group. For the FineVision/MicroF group, 
the spherical equivalent was 0.00 ± 0.23 D (range: -0.5 
to 0.5 D), the cylinder was -0.06 ± 0.16 D (range: -0.5 
to 0 D), and the sphere was 0.03 ± 0.19 D (-0.25 to 0.5 
D). The refractive outcomes at each follow-up visit are 
shown in Figure C (available in the online version of 
this article).
centratiOn
Table 2 summarizes IOL centration status with re-
spect to pupil edge for each IOL group and at each fol-
low-up visit. These data show that both IOLs provided 
good centration. Even though the POD FineVision IOL 
seems to provide slightly better centration than the 
FineVision/MicroF IOL, only the 1-month postopera-
tive differences were statistically significant.
Rotational stability was assessed using slit-lamp pho-
tographs at 1 day and 3 months following surgery. The 
Figure 2. The photograph of the lens in situ shows the triangle between 
the limbus center, the anatomic mark (blood vessel crossing in this case), 
and the haptic–optic junction.
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mean IOL rotation was 1.85° ± 1.01° for the POD FineVi-
sion group (range: 0.32° to 3.13°) and 3.30° ± 3.88° (range: 
0.26° to 11.26°) for the FineVision/MicroF group.
There were no statistically significant differences (P 
= .42) between the two groups due to the high standard 
deviation within the FineVision/MicroF group. In the 
odds ratio analysis, we had two IOLs that rotated more 
than 10° in the FineVision/MicroF group, whereas 
none of the IOLs in the POD FineVision group rotated 
more than 5°. This difference between groups was not 
statistically significant (z = 1.00, P = .31).
haLOMetry
The discrimination of peripheral stimuli in the 
presence of halos around a central stimulus was eval-
uated using the disturbance index. This index has a 
value between 0 and 1 and the greater the index, the 
lower the discrimination capacity. The discrimination 
index is equal to 1 minus the disturbance index. The 
outcomes of the halo quantification method are listed 
in Table 3. There was little visual disturbance with 
either IOL and no statistically significant differences 
emerged between the two groups. There was no cor-
TABLE 1
Visual Acuitya
IOL UDVA CDVA DCIVA 80 cm DCNVA 40 cm DCNVA 25 cm
Preoperative
   FineVision/MicroF – 0.16 ± 0.16  
(0.8 to 0.05)
– – –
   POD FineVision – 0.17 ± 0.18  
(0.7 to 0.05)
– – –
1 week postoperative
   POD FineVision 0.05 ± 0.06  
(0.2 to 0)
0.01 ± 0.02  
(0.05 to 0)
0.12 ± 0.07  
(0.3 to 0.0)
0.17 ± 0.10  
(0.4 to 0.0)
0.30 ± 0.11  
(0.5 to 0.1)
   FineVision/MicroF 0.04 ± 0.07  
(0.25 to 0)
0.01 ± 0.02  
(0.05 to 0)
0.11 ± 0.08  
(0.2 to -0.1)
0.15 ± 0.10  
(0.4 to 0.0)
0.27 ± 0.09  
(0.4 to 0.1)
1 month postoperative
   POD FineVision 0.03 ± 0.05  
(0.15 to 0)
0.00 ± 0.00  
(0.0 to 0.0)
0.13 ± 0.09  
(0.3 to 0.1)
0.12 ± 0.08  
(0.3 to 0.0)
0.30 ± 0.10  
(0.5 to 0.1)
   FineVision/MicroF 0.02 ± 0.04  
(0.15 to 0)
0.00 ± 0.002  
(0.05 to 0)
0.13 ± 0.10  
(0.3 to -0.1)
0.13 ± 0.11  
(0.4 to 0.0)
0.30 ± 0.07  
(0.4 to 0.1)
3 months postoperative
   POD FineVision 0.04 ± 0.07  
(0.2 to 0)
0.01 ± 0.04  
(0.15 to 0)
0.15 ± 0.11  
(0.3 to -0.1)
0.16 ± 0.08  
(0.3 to 0)
0.35 ± 0.11  
(0.6 to 0.2)
   FineVision/MicroF 0.03 ± 0.05  
(0.2 to 0)
0.01 ± 0.02  
(0.07 to 0)
0.17 ± 0.12  
(0.4 to -0.1)
0.14 ± 0.08  
(0.3 to 0.0)
0.34 ± 0.08  
(0.5 to 0.2)
IOL = intraocular lens; UCVA = uncorrected distance visual acuity; CDVA = corrected distance visual acuity; DCIVA = distance-corrected intermediate visual acuity; 
DCNVA = distance-corrected near visual acuity 
aValues are given as logMAR mean ± standard deviation (minimum to maximum). 
The lenses are manufactured by PhysIOL, Liège, Belgium.
TABLE 2
Mean Distance of the IOL Center to the Pupil Center (mm)
Time POD FineVision FineVision/MicroF P
Day of surgery (mm) 0.22 ± 0.12 0.27 ± 0.13 .69
1 day postoeprative (mm) 0.24 ± 0.11 0.29 ± 0.20 .33
1 week postoperative (mm) 0.20 ± 0.11 0.25 ± 0.13 .50
1 month postoperative (mm) 0.19 ± 0.10 0.30 ± 0.17 .032a
3 months postoperative (mm) 0.17 ± 0.06 0.24 ± 0.19 .25
IOL = intraocular lens 
aSignificant. 
The lenses are manufactured by PhysIOL, Liège, Belgium.
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relation between pupil diameter and the disturbance 
index (r2 < 0.001).
aberratiOnS and OpticaL QuaLity
The OPD Scan and OQAS were used to measure 
optical aberrations and image quality, respectively, 
following IOL implantation. The outcomes are shown 
in Table 4. There were no statistically significant dif-
ferences between the two groups’ outcomes except for 
TiltX (P = .008).
Although the MTF and Strehl ratio were close to 
that of a normal population, the OSI was higher. Nev-
ertheless, it remained, on average, within the range of 
the normal population (0.40 to -3.00).5
QueStiOnnaire
Subjective outcomes are illustrated in Figure 3 and 
are consistent with the halometry data. More halos were 
perceived with the POD FineVision IOL, although they 
were uncommon, and the disturbance was minimal.
Patients ranked their vision from 0 (blindness) to 10 
(perfect vision). The mean score was 8.29 ± 1.49 for far 
vision, 8.00 ± 1.71 for near vision, 8.31 ± 1.80 for inter-
mediate vision, and 7.29 ± 1.82 for night vision. Ninety 
percent of the patients stated that they would undergo 
surgery again if they had to. Two patients were not happy 
with their outcomes. One stated that he would not under-
go surgery again despite rating his vision at 8 of 10. The 
other patient was disturbed by the appearance of halos. 
Four additional patients also reported bothersome halos. 
Although scoring lower than day vision (P = .01), night 
vision was only 11% worse than day vision.
When patients were asked to compare the comfort 
provided by the two IOLs when looking at different dis-
tances, 66.77% of them reported perceiving no differenc-
es between the two IOLs, 14.29% of patients gave a better 
rating to the FineVision/Micro F model, and 19.05% of 
them preferred the POD FineVision model. Another fac-
tor that was relevant for the patients was the occurrence 
rate of dysphotopic phenomena, which may be related 
to the different optical zone sizes that these two lenses 
have. In this context, 95.24% of the patients found no dif-
ferences between the two eyes, whereas 4.76% of them 
perceived more halos with the POD FineVision model, 
which has a smaller 6-mm optical zone (Figure 6).
DISCUSSION
The two lenses evaluated in our study showed simi-
lar visual acuity scores, with no statistically significant 
differences between the lenses at any of the three dis-
tances evaluated or at any of the follow-up visits. This 
suggests that the difference in lens material is less rel-
TABLE 3
Halo Quantification Using the Discrimination Index and  
the Related Disturbance Index in Groups Implanted With the Two Lenses
Parameter FineVision/MicroF POD FineVision P
Discrimination index (linear) 0.92 ± 0.07 0.89 ± 0.09 .073
Discrimination index (quadratic) 0.95 ± 0.06 0.92 ± 0.08 .061
Disturbance index (linear) 0.08 ± 0.07 0.11 ± 0.09 .069
Disturbance index (quadratic) 0.05 ± 0.06 0.08 ± 0.08 .061
The lenses are manufactured by PhysIOL, Liège, Belgium.
TABLE 4
Aberrations and Image Quality Measured on Eyes Implanted With the Two Lenses
Parameter FineVision/MicroF POD FineVision
SA 0.24 ± 0.12 0.26 ± 0.19
HOA RMS internal 0.33 ± 0.16 0.33 ± 0.13
TiltX (µm) 0.11 ± 0.20 -0.08 ± 0.39
TiltY (µm) -0.04 ± 0.33 0.02 ± 0.42
OSI 2.18 ± 0.91 (1.1 to 4.7) 2.48 ± 1.08 (1.1 to 4.8)
MTF 29.21 ± 9.22 29.88 ± 12.95
Strehl ratio 0.18 ± 0.05 0.18 ± 0.06
SA = spherical aberration; HOA RMS = higher order aberrations root mean square; OSI = Objective Scattering Index; MTF = modulation transfer function 
The lenses are manufactured by PhysIOL, Liège, Belgium.
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evant than the diffractive design. Indeed, Marques and 
Ferreira6 showed statistical differences between AT 
Lisa Tri and FineVision/MicroF IOL performance for 
distance-corrected intermediate and near vision acuity.
The amount of addition plays a critical role in read-
ing distance. Several studies have shown that bifo-
cal IOLs with a higher addition power provide worse 
visual acuity in the intermediate range than lenses 
with lower addition power.7-10 Consequently, newly 
launched bifocal IOLs tend to have a design similar 
to previous models but with lower addition powers to 
improve visual outcomes in the intermediate range. 
Nevertheless, we must also be aware that a too low ad-
dition is detrimental for near vision.4 The results ob-
tained with trifocal IOLs show that including a third 
focal point (to improve intermediate vision) does not 
result in a loss of near visual acuity, as is the case with 
bifocal IOLs. Similarly, the inclusion of a third focal 
point does not compromise distance vision.12-17 Fur-
thermore, none of the patients included in our study 
reported postoperative spectacle dependence in per-
forming any of the activities of daily living. Both POD 
FineVision and FineVision/MicroF IOLs yielded a 
better visual acuity at 40 cm than at 25 cm, which is 
consistent with the visual requirements of modern life, 
such as the use of electronic devices including smart-
phones or tablets.
Regarding differences in material and haptic design, 
Bozukova et al.18 reported findings from a study in 
which 11 IOLs from different platforms were compared 
in vitro. The 4-loop haptic design lens (FineVision/Mi-
croF) showed greater compression in the capsular bag 
than the double C-loop haptic lens (POD FineVision), 
but that did not compromise IOL stability with regard 
to IOL position. Furthermore, they concluded that the 
double C-Loop or the 4-loop closed haptics employed 
by the two platforms evaluated in this study provide a 
moderate compression force contributing to the lens-
es’ anteroposterior stability. By contrast, in that same 
study, Bozukova et al.18 showed that plate haptic lens-
es (eg, the AT Lisa Tri lens) have lower formability and 
thereby provide higher radial compressive forces in 
the capsular bag. Similar to these ex vivo studies, our 
results show that the two lenses are stable, although 
the POD FineVision design was more centered and 
had higher rotational stability. Our outcomes with the 
double C-loop platform are consistent with the data 
published by Chassain.19,20
In terms of visual quality and Strehl ratio, the results 
obtained with FineVision/MicroF and POD FineVision 
models used in the current study are more robust than 
those presented by Mojzis et al.21 for the AT LisaTri 
lens. The MTF and OSI results were also excellent, but 
no clinical studies with other models of trifocal lens-
es have been published to date and, therefore, we are 
unable to discuss these particular findings within the 
context of other works.
In the current study, internal higher order aber-
Figure 3. Stack histogram showing answers to the questionnaire. Blue = FineVision/MicroF, red = POD FineVision, green = no difference. The lenses 
are manufactured by PhysIOL, Liège, Belgium.AQ4
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rations were similar for the two implanted models. 
Rohart et al.22 and Taketani et al.23 estimated that 
hydrophobic lenses caused greater aberrations than 
hydrophilic lenses. Photic phenomena such as halos 
or glare in multifocal lenses have been previously re-
ported.1,11,24 Moreover, it has been claimed that such 
phenomena are more prevalent with hydrophobic 
IOLs.25,26 In our study, patients were specifically ques-
tioned about photic phenomena and halometry was 
employed. For both investigations, although the dif-
ferences were slight, the objective and subjective data 
showed better values in the FineVision/MicroF lens 
group. Because the only difference between the two 
IOLs is the optical diameter (6.15 mm for the FineVi-
sion/MicroF and 6 mm for the POD FineVision) and no 
other visual outcomes were different, we believe that 
this must be the factor that explains the minimal dif-
ference in halo occurrence rate. Only one patient re-
ported edge dysphotopsia in one eye.
This study has limitations, mainly due to the small 
number of participating patients. Therefore, more ex-
tensive studies in terms of both number of patients 
and length of the follow-up period are needed to gain 
greater insight into these lenses’ behavior. A long-term 
study would be particularly useful to provide informa-
tion on the IOL material stability because hydrophilic 
IOLs may have calcification. The occurrence of calci-
fication is nevertheless low: in a study of 806 cases of 
IOLs with the same 26% hydrophilic acrylic raw mate-
rial as the POD FineVision IOL, Tassignon et al.27 re-
ported only two cases of calcification.
The double C-loop haptic design of the POD FineVi-
sion IOL provided good rotational stability while achiev-
ing similar visual performance to the FineVision/MicroF 
model. This study demonstrated the equivalence of the 
non-toric version of these two IOLs in terms of visual 
performance, to validate the material and the design of 
the POD FineVision IOL for toric versions. The toric POD 
FineVision IOL is available on the market and it will be 
interesting to directly measure the outcomes it achieves 
in term of quality of vision, refractive predictability, and 
positional stability.
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Figure A. Photograph of the “POD” IOL design (POD FineVision) with 
6-mm optical diameter and 11.4-mm total diameter. The lenses are 
manufactured by PhysIOL, Liège, Belgium.
Figure B. Photograph of the MicroF design (FineVision/MicroF; PhysIOL, 
Belgium) with 6.15-mm optical diameter and 10.75-mm total diameter. 
The lenses are manufactured by PhysIOL, Liège, Belgium.
TABLE A
Descriptive Statistics of the Preoperative Parameters for Both Groups
Parameter POD FineVision FineVision/MICROF
Axial length (mm) 23.36 ± 0.94 (21.32 to 25.31) 23.34 ± 0.97 (21.19 to 25.57)
Corneal power (D) 43.61 ± 1.09 (42.19 to 46.22) 43.73 ± 1.15 (41.80 to 46.44)
Astigmatism (D) -0.63 ± 0.36 (-1.54 to -0.17) -0.58 ± 0.38 (-1.48 to 0)
IOL power (D) 21.86 ± 2.86 (16.5 to 26.5) 21.60 ± 2.95 (15.5 to 1)
Photopic pupil diameter (mm) 4.14 ± 1.0.4 (2.00 to 6.00) 4.09 ± 1.08 (2.00 to 6.00)
Mesopic pupil diameter (mm) 5.24 ± 0.87 (3.80 to 6.60) 5.20 ± 0.92 (3.48 to 6.60)
D = diopters; IOL = intraocular lens 
The lenses are manufactured by PhysIOL, Liège, Belgium.
Figure C. Spherical equivalent, cylinder, and sphere at 1 week, 1 month, 
and 3 months (red = POD FineVision group; blue = FineVision/MicroF 
group). The lenses are manufactured by PhysIOL, Liège, Belgium.
